ATHA: Athira Pharma, Inc. Stock

by  •  • Comments Off on ATHA: Athira Pharma, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 13.54
Enterprise Value ($M) -34.90
Book Value ($M) 44.84
Book Value / Share 1.16
Price / Book 0.30
NCAV ($M) 40.90
NCAV / Share 1.06
Price / NCAV 0.33

Profitability (mra)
Return on Invested Capital (ROIC) -2.10
Return on Assets (ROA) -0.60
Return on Equity (ROE) -0.74

Liquidity (mrq)
Quick Ratio 4.18
Current Ratio 4.18

Balance Sheet (mrq) ($M)
Current Assets 54.84
Assets 58.78
Liabilities 13.94
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -96.78
Net Income -96.94

Cash Flow Statement (mra) ($M)
Cash From Operations -97.17
Cash from Investing 54.83
Cash from Financing 0.19

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A BML Investment Partners, L.P. 6.50 0.00
11-14 13G/A Baker Bros. Advisors Lp 0.00 -100.00
10-31 13D/A Perceptive Advisors Llc 14.20 0.38

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-08-09 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q/A (Amendment No. 1)
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 2,398 79,521 3.02
2025-03-06 16,966 137,382 12.35
2025-03-05 38,292 71,057 53.89
2025-03-04 31,806 268,799 11.83

(click for more detail)

Similar Companies
ARVN – Arvinas, Inc. ARWR – Arrowhead Pharmaceuticals, Inc.
ASMB – Assembly Biosciences, Inc. ATRA – Atara Biotherapeutics, Inc.
AVIR – Atea Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io